skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 156770 Find in a Library
Title: CEDIA (Cloned Enzyme Donor Immunoassay) for Screening Drugs of Abuse in Urine and the Effect of Adulterants
Journal: Journal of Forensic Sciences  Volume:40  Issue:4  Dated:(July 1995)  Pages:614-618
Author(s): A H B Wu; E Forte; G Casella; K Sun; G Hemphill; R Foery; H Schanzenbach
Date Published: 1995
Page Count: 5
Type: Test/Measurement
Format: Article
Language: English
Country: United States of America
Annotation: The performance of the Microgenics CEDIA (cloned enzyme donor immunoassay) assays for screening amphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine (PCP), and tetrahydrocannabinol (THC) was evaluated on the Boehringer Mannheim/Hitachi 717 in urine.
Abstract: Limits of detection ranged from 0.6 ng/mL for PCP, to 34.1 ng/mL for benzodiazepines. The average within run and total precision for these assays ranged from 1.3 percent to 7.3 percent for controls at cutoff concentrations, and control values at 125 percent and +25 percent of cutoffs. The rate separations by CEDIA between the negative and cutoff calibrators for all drugs were greater than corresponding EMIT II (Syva Co.) assays. The relative sensitivity and specificity of CEDIA as compared to EMIT II were 95.6 percent and 98.8 percent respectively on 13,535 urine samples. All positive samples and those samples that produced discordant results between the assays were confirmed by quantitative gas chromatography/mass spectrometry (GC/MS). Using SAMHSA cutoff limits and including barbiturates and benzodiazepines at 300 ng/mL, the relative sensitivity and specificity of CEDIA vs. EMIT II were 96.7 percent and 98.8 percent, respectively. The overall sensitivity of CEDIA compared to GC/MS was 98.9 percent with 179 false positives, compared to 96.2 percent with 189 false positives for EMIT II compared to GC/MS. The effect of adulterants added to urine to potentially invalidate screening results was also tested. CEDIA produced strong interferences for most drug assays in the presence of glutaraldehyde, detergent, and high concentrations of bleach and Drano. Minimal or selective interferences were seen with golden seal tea lemon juice, Visine, and low concentrations of bleach and Drano. Essentially no interference was observed with bicarbonate, sodium chloride, and vinegar. 5 tables and 5 references
Main Term(s): Drug testing
Index Term(s): Drug law enforcement; Urinalysis
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.